MELOXICAM
Generic: MELOXICAM
Lupin PharmaceuticalsManufacturer
ORALRoute
MELOXICAMActive Substance
2020-06-01Original Approval
MELOXICAM is FDA application ANDA209487, sponsored by LUPIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-03-15
Meloxicam Tablets, USP 7.5 mg 100 Tablets Rx Only NDC 69097-158-07 Manufactured for: Cipla USA, Inc. 9100 S. Dadeland BlCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II2022-01-26
Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; ManufactuCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi
Top Reported Reactions
1
DRUG INEFFECTIVE
6,104 reports
2
PAIN
4,822 reports
3
FATIGUE
4,757 reports
4
ARTHRALGIA
4,367 reports
5
NAUSEA
3,977 reports
6
HEADACHE
3,470 reports
7
DIARRHOEA
3,371 reports
8
DYSPNOEA
2,783 reports
9
DIZZINESS
2,734 reports
10
OFF LABEL USE
2,707 reports